COVID-19 mRNA Vaccine (nucleoside modified) [COVID-19 Vaccine Moderna] - Food and Drug Administration

COVID-19 mRNA Vaccine (nucleoside modified) [COVID-19 Vaccine Moderna]

Regulatory Information

Date

EUA Amendment of COVID-19 mRNA Vaccine (nucleoside modified) SPIKEVAX [COVID-19 Vaccine Moderna]

14 February 2023

EUA for Elasomeran + Imelasomeran [COVID-19 mRNA (nucleoside modified) Spikevax Bivalent Original/Omicron BA.1 Dispersion for Injection

22 December 2022

Product Information

For Vaccine Recipients and Healthcare Providers

For more information on reporting side effects, click here.

Shares